Howard Trachtman is a Nephrology physician. OpenAlex indexes 514 publications with 19,300 citations (h-index 68); ClinicalTrials.gov lists 10 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pediatric Nephrology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
227 E 30th St
New York, NY 100168203
Telephone
646-501-2663Registry record last updated 18 Jun 2013.
Clinical trials
- Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis
Sponsor: Travere Therapeutics, Inc.
- Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Sponsor: Uptal Patel
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20259 payments$34,450openpaymentsdata.cms.gov ↗
- Travere Therapeutics, Inc.Program year202515 payments$23,925openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim International GmbHProgram year202510 payments$11,728openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
8 NIH research awards on record, funded 1996–2020 per NIH RePORTER. The latest:
- Developmental Origins of Kidney Function in Early Life and Environmental Risks
New York University School of Medicine
FY2020$720,375R01ES032214 - Environmental Oxidant Stressors in Pediatric Chronic Kidney Disease - Resubmissio
New York University School of Medicine
FY2018$636,758R01DK100307 - Environmental Oxidant Stressors in Pediatric Chronic Kidney Disease - Resubmissio
New York University School of Medicine
FY2017$636,758R01DK100307
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
New England Journal of Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”